MARKET

ABPO

ABPO

ABPRO HLDGS INC
No Tier
0.5220
-0.2781
-34.76%
Closed 19:59 02/20 EST
OPEN
0.7590
PREV CLOSE
0.8001
HIGH
0.7797
LOW
0.5170
VOLUME
3.26M
TURNOVER
1
52 WEEK HIGH
34.65
52 WEEK LOW
0.5171
MARKET CAP
1.42M
P/E (TTM)
-0.0214
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at ABP last week (0216-0220)?
Weekly Report · 10h ago
Abpro Holdings Faces Nasdaq Delisting, Plans Appeal
TipRanks · 2d ago
Nasdaq Orders Abpro Holdings Delisting for Minimum Equity Noncompliance
Reuters · 2d ago
Weekly Report: what happened at ABP last week (0209-0213)?
Weekly Report · 02/16 09:13
Is Abpro Holdings Inc Gaining or Losing Market Support?
Benzinga · 02/12 15:00
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Benzinga · 02/12 12:05
Why Fastly Shares Are Trading Higher By Around 35%; Here Are 20 Stocks Moving Premarket
Benzinga · 02/12 09:31
Abpro Adds Independent Directors to Address Nasdaq Compliance
TipRanks · 02/11 21:56
More
About ABPO
Abpro Holdings, Inc. is a biotechnology company. The Company is advancing a pipeline of next generation antibody therapies for human epidermal growth factor receptor 2 (HER2)+cancers, non-HER2+ gastric and liver cancer, and wet age-related macular degeneration and diabetic macular edema. These antibodies are developed using the Company’s proprietary DiversImmune platform. Its two lead product candidates, ABP-102 and ABP-201, feature its next generation tetravalent antibody format (TetraBi antibody format), which binds to two different targets with two distinct binding sites per target. ABP-102 is designed to redirect a patient’s immune system to fight cancer by engaging T cells through co-targeting HER2, and CD3, T-cell co-receptor. ABP-201 is designed to block blood vessel formation and normalize damaged vessels through co-targeting VEGF and ANG-2. It plans to develop ABP-201 to treat vascular disease of the eye, focusing on wet age-related macular degeneration (Wet AMD).

Webull offers ABPRO Holdings Inc stock information, including No Tier: ABPO real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ABPO stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ABPO stock methods without spending real money on the virtual paper trading platform.